| Literature DB >> 32868229 |
Hila Magen1, Mika Geva2, Yulia Volchik3, Abraham Avigdor2, Arnon Nagler2.
Abstract
Entities:
Keywords: Heavily treated patients; Hematologic malignancies; Relapsing/refractory multiple myeloma; Selective inhibitor of nuclear export; Treatment response
Year: 2020 PMID: 32868229 DOI: 10.1016/j.clml.2020.07.016
Source DB: PubMed Journal: Clin Lymphoma Myeloma Leuk ISSN: 2152-2669